일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
2013/10/12 | 05:46 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/12 | 05:37 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 19:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 19:00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:43 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:42 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:40 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:39 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:38 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:36 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:35 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:34 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:33 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:31 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:30 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:29 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:28 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:27 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:24 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:23 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:22 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:19 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:17 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:14 | Edgar (US Regulatory) | Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:13 | Edgar (US Regulatory) | Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/02 | 05:05 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/01 | 21:58 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/01 | 19:34 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/01 | 19:21 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
2013/10/01 | 19:00 | PR Newswire (US) | Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |